Cargando…
Cancer antigen-125 plasma level as a biomarker of new-onset atrial fibrillation in postmenopausal women
OBJECTIVE: Plasma cancer antigen (CA)-125 is a tumour marker recently shown to be associated with systolic heart failure and new-onset atrial fibrillation (AF) after myocardial infarction. However, no reports have described the relationship between CA-125 and new-onset AF in healthy postmenopausal w...
Autores principales: | Sekiguchi, Haruki, Shimamoto, Ken, Takano, Mayu, Kimura, Makiko, Takahashi, Yufuko, Tatsumi, Fujio, Watanabe, Eri, Jujo, Kentaro, Ishizuka, Naoko, Kawana, Masatoshi, Hagiwara, Nobuhisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Heart
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561355/ https://www.ncbi.nlm.nih.gov/pubmed/28285269 http://dx.doi.org/10.1136/heartjnl-2016-310272 |
Ejemplares similares
-
Impact of cascade screening for catecholaminergic polymorphic ventricular tachycardia type 1
por: Shimamoto, Keiko, et al.
Publicado: (2022) -
Reducing radiation exposure during atrial fibrillation ablation using lectures to promote awareness
por: Miwa, Yosuke, et al.
Publicado: (2019) -
Atrial fibrillation associated with ivabradine treatment: meta-analysis of randomised controlled trials
por: Martin, Ruairidh I R, et al.
Publicado: (2014) -
Genetic, clinical and pharmacological determinants of out-of-hospital cardiac arrest: rationale and outline of the AmsteRdam Resuscitation Studies (ARREST) registry
por: Blom, M T, et al.
Publicado: (2014) -
Sudden Unexpected Death in North Carolina (SUDDEN): methodology review and screening results
por: Nanavati, Parin P, et al.
Publicado: (2014)